Last reviewed · How we verify
NKTR118 Formulation 1
At a glance
| Generic name | NKTR118 Formulation 1 |
|---|---|
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Bioavailability Study With Alternate Methods of Administration of Naloxegol Tablets, and Solution (PHASE1)
- Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol (PHASE1)
- Assessment of Relative Bioavailability of NKTR-118 in Three Formulations in Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |